IN2015DN02807A - - Google Patents

Download PDF

Info

Publication number
IN2015DN02807A
IN2015DN02807A IN2807DEN2015A IN2015DN02807A IN 2015DN02807 A IN2015DN02807 A IN 2015DN02807A IN 2807DEN2015 A IN2807DEN2015 A IN 2807DEN2015A IN 2015DN02807 A IN2015DN02807 A IN 2015DN02807A
Authority
IN
India
Prior art keywords
crystalline phase
absd
disulfanediylbis
aminobutane
lysine
Prior art date
Application number
Other languages
English (en)
Inventor
Fabrice; Balavoine
Jean-Marie; Schneider
Gerard; Coquerel
Nicolas; Couvrat
Original Assignee
Quantum Genomics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quantum Genomics filed Critical Quantum Genomics
Publication of IN2015DN02807A publication Critical patent/IN2015DN02807A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • C07C319/28Separation; Purification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/145Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38Separation; Purification; Stabilisation; Use of additives
    • C07C227/40Separation; Purification
    • C07C227/42Crystallisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/66Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN2807DEN2015 2012-10-22 2013-10-22 IN2015DN02807A (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306307.5A EP2722327A1 (en) 2012-10-22 2012-10-22 Crystalline phase of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid) with L-lysine
PCT/EP2013/072028 WO2014064077A1 (en) 2012-10-22 2013-10-22 Crystalline phase of (3s.3s') 4,4'-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine

Publications (1)

Publication Number Publication Date
IN2015DN02807A true IN2015DN02807A (pl) 2015-09-11

Family

ID=47278723

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2807DEN2015 IN2015DN02807A (pl) 2012-10-22 2013-10-22

Country Status (30)

Country Link
US (2) US9278921B2 (pl)
EP (2) EP2722327A1 (pl)
JP (1) JP6317358B2 (pl)
KR (1) KR102103407B1 (pl)
CN (1) CN104768927B (pl)
AR (1) AR093070A1 (pl)
AU (1) AU2013336738B2 (pl)
BR (1) BR112015008931B1 (pl)
CA (1) CA2884914C (pl)
CY (1) CY1119913T1 (pl)
DK (1) DK2909169T3 (pl)
EA (1) EA024460B1 (pl)
ES (1) ES2658413T3 (pl)
HK (1) HK1212321A1 (pl)
HR (1) HRP20180189T1 (pl)
HU (1) HUE036037T2 (pl)
IL (1) IL237733B (pl)
IN (1) IN2015DN02807A (pl)
LT (1) LT2909169T (pl)
ME (1) ME02955B (pl)
MX (1) MX353693B (pl)
NO (1) NO2909169T3 (pl)
NZ (1) NZ706070A (pl)
PL (1) PL2909169T3 (pl)
PT (1) PT2909169T (pl)
RS (1) RS56896B1 (pl)
SI (1) SI2909169T1 (pl)
TW (1) TWI643842B (pl)
WO (1) WO2014064077A1 (pl)
ZA (1) ZA201503574B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103951562B (zh) * 2014-05-09 2016-04-20 四川九章生物化工科技发展有限公司 一种绿原酸晶型及其制备方法
WO2022225712A1 (en) * 2021-04-22 2022-10-27 Teva Pharmaceuticals International Gmbh Solid state forms of firibastat and processes for preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235687B2 (en) 2002-07-16 2007-06-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Derivatives of 4,4′-dithiobis-(3-aminobutane-1-sulfphonates) and compositions containing same
FR2858617A1 (fr) * 2003-08-06 2005-02-11 Inst Nat Sante Rech Med Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant
TWI370818B (en) * 2006-04-05 2012-08-21 Astellas Pharma Inc Cocrystal of c-glycoside derivative and l-proline
EP2439192A1 (en) 2010-10-07 2012-04-11 Quantum Genomics Method for the preparation of (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid)
US9447050B2 (en) * 2011-04-05 2016-09-20 The Translational Genomics Research Institute Solid forms of curcumin

Also Published As

Publication number Publication date
EP2722327A1 (en) 2014-04-23
RS56896B1 (sr) 2018-04-30
US9278921B2 (en) 2016-03-08
PT2909169T (pt) 2018-02-26
US20160221940A1 (en) 2016-08-04
JP6317358B2 (ja) 2018-04-25
AU2013336738B2 (en) 2017-05-18
HK1212321A1 (en) 2016-06-10
CA2884914A1 (en) 2014-05-01
PL2909169T3 (pl) 2018-07-31
EP2909169B1 (en) 2018-01-03
US20150284325A1 (en) 2015-10-08
BR112015008931A2 (pt) 2017-07-04
ES2658413T3 (es) 2018-03-09
MX353693B (es) 2018-01-24
EA201500438A1 (ru) 2015-09-30
NZ706070A (en) 2018-11-30
CN104768927A (zh) 2015-07-08
HRP20180189T1 (hr) 2018-04-20
ME02955B (me) 2018-07-20
NO2909169T3 (pl) 2018-06-02
US9487477B2 (en) 2016-11-08
MX2015005059A (es) 2015-11-23
AU2013336738A1 (en) 2015-04-09
HUE036037T2 (hu) 2018-06-28
KR102103407B1 (ko) 2020-04-22
SI2909169T1 (en) 2018-04-30
CA2884914C (en) 2021-01-05
BR112015008931B1 (pt) 2021-05-18
CY1119913T1 (el) 2018-06-27
EP2909169A1 (en) 2015-08-26
CN104768927B (zh) 2017-06-09
DK2909169T3 (en) 2018-02-26
WO2014064077A1 (en) 2014-05-01
ZA201503574B (en) 2016-01-27
AR093070A1 (es) 2015-05-13
JP2015536316A (ja) 2015-12-21
IL237733B (en) 2019-03-31
KR20150072454A (ko) 2015-06-29
TW201418202A (zh) 2014-05-16
LT2909169T (lt) 2018-04-25
EA024460B1 (ru) 2016-09-30
TWI643842B (zh) 2018-12-11

Similar Documents

Publication Publication Date Title
CY1120805T1 (el) Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης
WO2014028589A3 (en) 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
WO2012076466A3 (de) Substituierte 1-benzylcycloalkylcarbonsäuren und ihre verwendung
MX2015003021A (es) Derivados de acido glicirretinico y metodos de uso de los mismos.
TN2013000239A1 (en) New form of administration of enkephalinase inhibitor
PH12014502512A1 (en) Topical pharmaceutical compositions comprising terbinafine and urea
MX340147B (es) Composiciones farmacéuticas y nutracéuticas del ácido abscísico.
WO2012051407A3 (en) Molecular containers and methods of making and using same
CA2899024C (en) Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
IN2011KN05169A (pl)
IN2015DN02807A (pl)
CA2901220C (en) Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
WO2012150607A3 (en) Oral liquid composition comprising divalproex sodium and process for preparing thereof
WO2011152657A3 (en) Acetyl-l-carnitine malate, process for preparing the same, and pharmaceutical composition comprising the same
TN2014000106A1 (en) Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
WO2013064326A3 (de) Arjunolsäure zur erhöhung der sebumproduktion
TN2013000243A1 (en) Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
UA99014C2 (ru) Метиловый эстер n-[(2-оксоиндолинилиден-3)-2-оксиацетил]аминоуксусной кислоты, который проявляет противовоспалительное действие
MX2012013055A (es) Un procedimiento mejorado para purificar el complejo de cloruro de benzalconio-dialil oxido de disulfuro modificado y usos.
UA105665C2 (uk) 3-метиламіносукциноїламідо-n-(3&#39;,4&#39;-диметилфеніл)антранілова кислота, що проявляє протизапальну, анальгетичну, діуретичну та протигрибкову активність